TY  - JOUR
AU  - Mena-Vazquez, Natalia
AU  - Rojas-Gimenez, Marta
AU  - Fuego-Varela, Clara
AU  - Garcia-Studer, Aimara
AU  - Perez-Gomez, Nair
AU  - Romero-Barco, Carmen Maria
AU  - Godoy-Navarrete, Francisco Javier
AU  - Manrique-Arija, Sara
AU  - Gandia-Marinez, Myriam
AU  - Calvo-Gutierrez, Jerusalem
AU  - Morales-Garrido, Pilar
AU  - Mouriño-Rodriguez, Coral
AU  - Castro-Perez, Patricia
AU  - Añon-Oñate, Isabel
AU  - Espildora, Francisco
AU  - Aguilar-Hurtado, Maria Carmen
AU  - Hidalgo-Conde, Ana
AU  - Arnedo-Diez de-Los-Rios, Rocio
AU  - Cabrera-Cesar, Eva
AU  - Redondo-Rodriguez, Rocio
AU  - Velloso-Feijoo, Maria Luisa
AU  - Fernandez-Nebro, Antonio
PY  - 2022
DO  - 10.3390/biomedicines10071480
SN  - 2227-9059
UR  - http://hdl.handle.net/10668/20838
T2  - Biomedicines
AB  - To prospectively evaluate the safety and efficacy profile of abatacept in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). We performed a prospective observational multicenter study of a cohort of patients with RA-ILD...
LA  - en
PB  - MDPI
KW  - Abatacept
KW  - Biologics
KW  - Interstitial lung disease
KW  - Rheumatoid arthritis
KW  - AGS - Jerez, Costa Noroeste y Sierra de Cádiz
KW  - AGS - Sur de Sevilla
KW  - Carbon monoxide
KW  - Follow-up studies
KW  - Blood sedimentation
KW  - Arthritis, rheumatoid
KW  - Lung diseases, interstitial
KW  - Respiratory function tests
KW  - Vital capacity
KW  - Regression analysis
TI  - Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease.
TY  - Research article
VL  - 10
ER  -